273 related articles for article (PubMed ID: 29471342)
21. Progress towards elimination of onchocerciasis in the Region du Sud-Ouest of Burkina Faso which was previously subject to a recrudescence event after vector control.
Nikièma AS; Koala L; Post RJ; Kima A; Compaoré J; Kafando CM; Nana JB; Bougouma C; Faye B; Traoré S; Dabiré RK
PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012118. PubMed ID: 38683750
[TBL] [Abstract][Full Text] [Related]
22. Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
Pion DS; Gardon J; Kamgno J; Gardon-Wendel N; Chippaux JP; Boussinesq M
Parasitology; 2004 Nov; 129(Pt 5):613-26. PubMed ID: 15552406
[TBL] [Abstract][Full Text] [Related]
23. Onchocerciasis control: biological research is still needed.
Boussinesq M
Parasite; 2008 Sep; 15(3):510-4. PubMed ID: 18814732
[TBL] [Abstract][Full Text] [Related]
24. Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
Colebunders R; Kaiser C; Basáñez MG; Olliaro P; Lakwo T; Siewe Fodjo JN
Int J Infect Dis; 2022 Mar; 116():302-305. PubMed ID: 35074518
[TBL] [Abstract][Full Text] [Related]
25. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
26. Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
Turner HC; Walker M; Churcher TS; Osei-Atweneboana MY; Biritwum NK; Hopkins A; Prichard RK; Basáñez MG
Clin Infect Dis; 2014 Oct; 59(7):923-32. PubMed ID: 24944228
[TBL] [Abstract][Full Text] [Related]
27. Research for new drugs for elimination of onchocerciasis in Africa.
Kuesel AC
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):272-286. PubMed ID: 27693536
[TBL] [Abstract][Full Text] [Related]
28. Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis.
Tamarozzi F; Tendongfor N; Enyong PA; Esum M; Faragher B; Wanji S; Taylor MJ
Parasit Vectors; 2012 Mar; 5():53. PubMed ID: 22433114
[TBL] [Abstract][Full Text] [Related]
29. Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.
Kouam MK; Tchatchueng-Mbougua JB; Demanou M; Boussinesq M; Pion SD; Kamgno J
Parasit Vectors; 2013 Sep; 6(1):283. PubMed ID: 24289520
[TBL] [Abstract][Full Text] [Related]
30. Factors affecting onchocerciasis transmission: lessons for infection control.
Cheke RA
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):377-386. PubMed ID: 28117596
[TBL] [Abstract][Full Text] [Related]
31. Loiasis is endemic in the Ndikinimeki Health District (Centre Region, Cameroon) but does not represent a hindrance to onchocerciasis elimination.
Sumo L; Ntonifor NH; Afor AR; Bopda J; Bamou Heumou R; Ondoua Nganjou GS; Nana Djeunga HC
Acta Trop; 2022 Jan; 225():106218. PubMed ID: 34755644
[TBL] [Abstract][Full Text] [Related]
32. A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon.
Lenk EJ; Moungui HC; Boussinesq M; Kamgno J; Nana-Djeunga HC; Fitzpatrick C; Peultier AMM; Klion AD; Fletcher DA; Nutman TB; Pion SD; Niamsi-Emalio Y; Redekop WK; Severens JL; Stolk WA
Clin Infect Dis; 2020 Apr; 70(8):1628-1635. PubMed ID: 31165855
[TBL] [Abstract][Full Text] [Related]
33. Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.
Otubanjo OA; Adeoye GO; Ibidapo CA; Akinsanya B; Okeke P; Atalabi T; Adejai ET; Braide E
Rev Biol Trop; 2008 Dec; 56(4):1635-43. PubMed ID: 19419072
[TBL] [Abstract][Full Text] [Related]
34. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
[TBL] [Abstract][Full Text] [Related]
35. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
36. Onchocerciasis control in Ghana (1974-2016).
Biritwum NK; de Souza DK; Asiedu O; Marfo B; Amazigo UV; Gyapong JO
Parasit Vectors; 2021 Jan; 14(1):3. PubMed ID: 33388081
[TBL] [Abstract][Full Text] [Related]
37. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon.
Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Abong RA; Enyong P; Taylor DW
Parasit Vectors; 2015 Dec; 8():667. PubMed ID: 26715524
[TBL] [Abstract][Full Text] [Related]
38. The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data.
Turner HC; Walker M; Attah SK; Opoku NO; Awadzi K; Kuesel AC; Basáñez MG
Parasit Vectors; 2015 Mar; 8():167. PubMed ID: 25889256
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.
Blok DJ; Kamgno J; Pion SD; Nana-Djeunga HC; Niamsi-Emalio Y; Chesnais CB; Mackenzie CD; Klion AD; Fletcher DA; Nutman TB; de Vlas SJ; Boussinesq M; Stolk WA
Clin Infect Dis; 2021 Jun; 72(12):e1047-e1055. PubMed ID: 33289025
[TBL] [Abstract][Full Text] [Related]
40. Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon.
Forrer A; Wanji S; Obie ED; Nji TM; Hamill L; Ozano K; Piotrowski H; Dean L; Njouendou AJ; Ekanya R; Ndongmo WPC; Fung EG; Nnamdi DB; Abong RA; Beng AA; Eyong ME; Ndzeshang BL; Nkimbeng DA; Teghen S; Suireng A; Ashu EE; Kah E; Murdoch MM; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33431378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]